Kalman Filanovsky - Concepedia

Author

Kalman Filanovsky

Kaplan Medical Center

Also Known As

K Filanovsky, K. Filanovsky, K., Filanovsky, Kalman Filanovsky, Moshe Mittelman, O. Katz

Publications

442

Citations

H-Index

Concepts

All Affiliations

Kaplan Medical Center Hadassah Medical Center Technion – Israel Institute of Technology Rabin Medical Center Meir Medical Center

About

Kalman Filanovsky is an author at Kaplan Medical Center specializing in hematology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	160
2	Biostatistics	1	1	121
3	Cellular Therapies	1	1	17
4	Emergency Medicine	1	1	121
5	Immunology	1	1	17

Kalman Filanovsky

Publications

312

Citations

H-Index

Page 1

	Year	Citations
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study Patrice Chevallier, Myriam Labopin, Pascal Turlure, Leukemia Hematological MalignancyPrognostic EvaluationMedicineMixed-phenotype Acute LeukemiaPrognosis	2011	121
Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study Drorit Merkel, Kalman Filanovsky, Anat Gafter‐Gvili, American Journal of Hematology	2012	67
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience Yafit Segman, Elena Ribakovsky, Abraham Avigdor, Leukemia & lymphoma/Leukemia and lymphoma	2020	35
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim <scp>PET</scp>/<scp>CT</scp> is beneficial: a prospective multicentre trial of 355 patients Eldad J. Dann, Osnat Bairey, Rachel Bar‐Shalom, British Journal of Haematology	2017	33
Higher Infection Rate After 7- Compared With 5-Day Cycle of Azacitidine in Patients With Higher-Risk Myelodysplastic Syndrome Yishai Ofran, Kalman Filanovsky, Anat Gafter‐Gvili, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyHigher-risk Myelodysplastic SyndromeHematologyHigher Infection RateMedicine	2015	22
Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab Kalman Filanovsky, Edward B. Miller, Erica Sigler, Recent Patents on Anti-Cancer Drug Discovery	2016	17
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg? Vladimir Vainstein, Batia Avni, Sigal Grisariu, Cancers Cell TherapyWhether Cart TherapyImmunologyPathologyImmunotherapy	2023	17

Page 1